Pharmaceuticals

Oral Vaccine Market Forecast 2026–2035: How to Leverage Market Growth

February 17, 2026February 18, 2026 by Marketing Posting

Uncover key drivers, emerging technologies, and competitive movements shaping the oral vaccine market from 2026–2035 with trusted insights from The Business Research Company

Starting from its 2026 valuation, what market size is the Oral Vaccine Market expected to reach by 2030?

The oral vaccine market has experienced substantial growth in recent years. It is projected to expand from $3.95 billion in 2025 to $4.35 billion in 2026, with a compound annual growth rate (CAGR) of 10.0%. The historical increase in the market size can be attributed to the prevalence of vaccine-preventable diseases, a rising awareness of immunization benefits, government vaccination initiatives, the development of oral polio and cholera vaccines, and the growth of hospital and clinic vaccination programs.

The oral vaccine market is projected to experience robust expansion in the coming years. This market is set to reach a valuation of $6.29 billion by 2030, exhibiting a compound annual growth rate (CAGR) of 9.7%. The anticipated growth during this period stems from several factors, including the introduction of innovative oral vaccines (such as DNA, RNA, and VLP types), the broadening of worldwide immunization initiatives, the incorporation of digital health and surveillance technologies, escalating financial commitments to vaccine research and development, and a heightened emphasis on vaccinations for adults and travelers. Key trends expected over the forecast horizon encompass a greater uptake of oral vaccines for childhood immunization, a growing emphasis on proactive healthcare and large-scale vaccination drives, the creation of live attenuated and subunit oral vaccine formulations, the proliferation of government-backed immunization efforts, and the integration of advancements in cold chain and logistics for vaccine delivery.

Access Your Free Sample Report for In-Depth Market Insights:

https://www.thebusinessresearchcompany.com/sample.aspx?id=27373&type=smp

What Drivers Are Driving Adoption Within The Oral Vaccine Market?

The increasing occurrence of infectious diseases is anticipated to boost the expansion of the oral vaccine market in the future. These illnesses are caused by detrimental microorganisms such as bacteria, viruses, fungi, or parasites, capable of spreading between individuals or through environmental factors. The rise in infectious diseases is attributed to augmented global travel, which enables the rapid transmission of people and pathogens across borders, thereby accelerating the worldwide spread of infections. Oral vaccines prove beneficial for infectious diseases as they stimulate mucosal immunity in the gut, a primary entry point for numerous pathogens, consequently providing effective protection at the infection site. For instance, in May 2025, the Health Security Agency, a UK-based government department, indicated that England experienced an 11.0% increase in reported tuberculosis (TB) cases in 2023 compared to 2022. Therefore, the growing prevalence of infectious diseases is significantly driving the oral vaccine market’s growth.

How Is The Oral Vaccine Market Organized Into Various Segments?

The oral vaccine market covered in this report is segmented –

1) By Vaccine Type: Live Attenuated Vaccines, Inactivated Vaccines, Subunit Vaccines, Other Vaccine Types

2) By Application: Polio, Cholera, Other Applications

3) By End-User: Hospital , Clinics, Government Organization, Other End-Users

Subsegments:

1) By Live Attenuated Vaccines: Oral Polio Vaccine (OPV), Rotavirus Vaccine, Oral Typhoid Vaccine, Oral Cholera Vaccine

2) By Inactivated Vaccines: Inactivated Polio Vaccine (IPV), Inactivated Cholera Vaccine, Inactivated Hepatitis A Vaccine

3) By Subunit Vaccines: Protein Subunit Vaccines, Polysaccharide Vaccines, Conjugate Vaccines

4) By Other Vaccine Types: Virus-Like Particle (VLP) Vaccines, Recombinant Vector Vaccines

Which Trends Are Influencing The Development Of The Oral Vaccine Market?

Prominent companies within the oral vaccine market are prioritizing the development of innovative offerings, such as advanced second-generation oral pill vaccines, to enhance immune response and simplify administration. A second-generation pill-based oral vaccine is engineered to boost immunogenicity, extend protective reach, and streamline mass immunization by removing the need for needles or cold-chain storage. For instance, in March 2025, Vaxart Inc., a U.S.-based biotechnology company, announced the start of a Phase 1 clinical trial for its second-generation oral norovirus vaccine, which is delivered as a pill. This trial intends to assess improved immune responses and safety attributes of the updated formulations, aiming to fulfill the continuous global requirement for accessible and effective norovirus immunization. The pill configuration eliminates hurdles linked to injectable vaccines and facilitates swift, widespread distribution, especially critical during outbreaks.

Who Are The Prominent Global Companies Shaping The Oral Vaccine Market Landscape?

Major companies operating in the oral vaccine market are Panacea Biotec Ltd., Zydus Lifesciences, Serum Institute of India Pvt. Ltd., Bharat Biotech Ltd., Haffkine Biopharmaceutical Co. Ltd., Medigen Vaccine Biologics Corp., BlueWillow Biologics Inc.

Access The Complete Report For Deeper Market Insights:

https://www.thebusinessresearchcompany.com/report/oral-vaccine-global-market-report

Which Geographic Areas Are Emerging As Strong Markets For The Oral Vaccine Market?

North America was the largest region in the oral vaccine market in 2025. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the oral vaccine market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

Request Your Customized Oral Vaccine Market Research Report for Competitive Advantage:

https://www.thebusinessresearchcompany.com/customise?id=27373&type=smp

Browse Through More Reports Similar to the Global Oral Vaccine Market 2026, By The Business Research Company

Sandwich Panels Market Report 2026

https://www.thebusinessresearchcompany.com/report/sandwich-panels-global-market-report

Structural Insulated Panels Market 2026

https://www.thebusinessresearchcompany.com/report/structural-insulated-panels-market

Polyurethane Sealants Pu Market Report 2026

https://www.thebusinessresearchcompany.com/report/polyurethane-sealants-pu-global-market-report

Get in touch with us:

The Business Research Company: https://www.thebusinessresearchcompany.com/

Americas +1 310-496-7795